Sa1145 - Predictors for Early Versus Delayed Response to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis Treatment: A Subgroup Analysis from the Pivotal Trial Eos-1
Alex Straumann(University of Zurich), Alfredo J. Lucendo(Hospital General de Tomelloso), Alain Schoepfer(University Hospital of Lausanne), Ralph Müeller(Dr Falk Pharma (Germany)), Michael Vieth(Bayreuth Medical Center), Stefan Schubert, Ulrike von Arnim, Jan Tack(KU Leuven), Albert J. Bredenoord(Amsterdam Neuroscience), Dirk Hartmann, Christoph Schlag, Stefan Brückner, Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Javier Molina‐Infante(Complejo Hospitalario de Cáceres), Roland Greinwald(Dr Falk Pharma (Germany)), Constanza Ciriza de los Ríos(Hospital Clínico San Carlos), Jamal Hayat, Stephen E. Attwood(Durham University), Ahmed Madisch(Technische Universität Dresden)
Cited by 2
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k